WEBINAR | Multi-sponsor Pregnancy Exposure Registries: Physician, Scientific Advisory and Industry Insights
Pregnancy exposure registries play a crucial role in assessing the safety of medications used during pregnancy. Despite their importance, these studies often face significant challenges such as slow enrollment, low patient numbers and extended study durations. Both the FDA's 2019 draft guidance and the EMA's Guidelines on Good Pharmacovigilance Practices emphasize the need for collaborative multi-product registries, but creating and managing these multi-sponsor efforts comes with a multitude of challenges.
This webinar unveils insights from experts on the scientific methodologies, regulatory precedents, and industry insights that are driving best practices for success.
Related Content
Looking for exclusive insight?
